StemRIM Inc.
Presentation Material for Business Plan and Growth Potential
Filed with TSE ·
6ix is reading this filing.
View original source (TDnet)StemRIM Inc. on 6ix
In the deck
Earlier from StemRIM
- Notice Regarding US Patent Registration of SR-GT1 for Dystrophic Epidermolysis Bullosa
- Patent Registration in South Korea for Redasemtide in Cartilage Disorders
- StemRIM Announces Fixed Details of the Issuance of Stock Options to Employees
- StemRIM Announces Issuance of Stock Acquisition Rights as Stock Options to Employees
- StemRIM Announces Patent Registration for SR-GT1 Aimed at Curative Treatment of Dystrophic Epidermolysis Bullosa in South Korea
Follow StemRIM into a list and get an email when it puts out news.
Follow StemRIM